Pfizer Income from Continuous Operations 2010-2024 | PFE

Pfizer income from continuous operations for the twelve months ending June 30, 2024 was $-2.564B, a 111.9% decline year-over-year.

  • Pfizer annual income from continuous operations for 2023 was $2.172B, a 93.08% decline from 2022.
  • Pfizer annual income from continuous operations for 2022 was $31.401B, a 39.81% increase from 2021.
  • Pfizer annual income from continuous operations for 2021 was $22.459B, a 236.92% increase from 2020.

Pfizer Income from Continuous Operations 2010-2024 | PFE

  • Pfizer annual income from continuous operations for 2023 was $2.172B, a 93.08% decline from 2022.
  • Pfizer annual income from continuous operations for 2022 was $31.401B, a 39.81% increase from 2021.
  • Pfizer annual income from continuous operations for 2021 was $22.459B, a 236.92% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Sanofi (SNY)$133B
Innoviva (INVA)$953M